drugset / Trial / NCT00159380

Nitric Oxide (NO) Donors and Inhibitors Study: Study to Evaluate L-Arginine and Aminoguanidine in Asthmatic Subjects

NCT00159380 ↗

Completed 16 enrolled Imperial College London
RandomizedCrossoverDouble-blindTreatment

Summary

The primary aim of this study is to investigate the effects of oral and inhaled administration of L-arginine and of inhaled aminoguanidine on bronchial and alveolar exhaled NO and NO metabolites in exhaled breath condensate, saliva and nasal lavage fluid in normal and asthmatic subjects.

Timeline

Start
2003-09
Primary completion
2005-03
Completion
2005-03

Drugs

EvaluationDrugModalityDoseRoute
Subject PIMAGEDINE Small molecule 500 mg Inhaled

Indications